IBA reports strong Half Year 2025 results, transforming towards a more profitable business

Read the entire half year 2025 results press release  hereLouvain-la-Neuve, Belgium, 28 August 2025- IBA (Ion Beam Applications S.A), the world leader in particle accelerator technology, today announces its consolidated results for the first half of 2025. High revenue growth and improved profitability in H1 driven by accelerated backlog conversionNet sales rose 40% vs. H1 2024, to EUR 304.9 million, with IBA Clinical and IBA Technologies increasing by 47% and 30%...

Louvain-la-neuve, 28/08/2025 (informazione.news - comunicati stampa - salute e benessere)

Read the entire half year 2025 results press release   here

- IBA (Ion Beam Applications S.A), the world leader in particle accelerator technology, today announces its consolidated results for the first half of 2025.

____________________________________________

Enterprise Resource Planning system, anticipated to be completed by early 2026

  H1 2024 figures restated to reflect IFRS15 Agent vs. Principal treatment change and new segmentation, announced at year-end 2024 results publication. More information can be found in the Appendix.

***ENDS***

IBA’s management team will host team will host a conference call and webcast conducted in English to present the half year results, followed by a Q&A session.

The conference call will be held on Thursday, 28 August 2025 at 3pm CEST / 2pm BST / 9am EDT / 6am PDT as a Teams webinar. To attend the webcast, register via this link. Please complete the registration at least 15 minutes before the start of the event.

The presentation will be available on IBA’s investor relations website and on: https://www.iba-worldwide.com/iba-half-year-2025-results-presentation-and-press-release  shortly before the call.

To ensure a timely connection, it is recommended that users register at least 10 minutes prior to the scheduled webcast.

Financial calendar
Business Update Q3 2025                                       20 November 2025
Full Year Results 2025                                             26 March 2026
Business Update First Quarter 2026                        21 May 2026
Half Year Results 2026                                            27 August 2026

About IBA

IBA (Ion Beam Applications S.A.) is the world leader in particle accelerator technology. The company is the leading supplier of equipment and services in the fields of proton therapy, considered as the most advanced form of radiation therapy available today, as well as industrial sterilization, radiopharmaceuticals and dosimetry. The company, based in Louvain-la-Neuve, Belgium, employs approximately 2,100 people worldwide. IBA is a certified B Corporation (B Corp) meeting the highest standards of verified social and environmental performance.

IBA is listed on the pan-European stock exchange EURONEXT (IBA: Reuters IBAB.BR and Bloomberg IBAB.BB). More information can be found at: www.iba-worldwide.com

For further information, please contact:
IBA

Attachment